Mechanistically, DBC1 promotes anoikis resistance and metastatic potential in tumor cells by activating the IKKβ/NF-κB signaling pathway and upregulating anti-apoptotic genes such as c-FLIP and Bcl-xL. The gene discussed is NFKB1; the disease is neoplasm.